TherapeuticsMD (TXMD) Revenue Growth (1y) (2012 - 2026)
TherapeuticsMD (TXMD) Revenue Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -0.81% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -0.24% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.92% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 4.88% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 39.49% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 10.23% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | -8.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.72% |
| Mar 31, 2026 | 84.22% |
| Dec 31, 2025 | 33.88% |
| Sep 30, 2025 | 43.33% |
| Jun 30, 2025 | 306.84% |
| Mar 31, 2025 | 25.56% |
| Dec 31, 2024 | 42.22% |
| Sep 30, 2024 | 932.08% |
| Jun 30, 2024 | -46.45% |
| Mar 31, 2024 | -24.76% |
| Dec 31, 2023 | -99.32% |
| Sep 30, 2023 | -85.03% |
| Jun 30, 2023 | 25.57% |
| Mar 31, 2023 | -40.14% |
| Dec 31, 2022 | 267.09% |
| Sep 30, 2022 | -98.61% |
| Jun 30, 2022 | -98.49% |
| Mar 31, 2022 | -96.50% |
| Dec 31, 2021 | -17.27% |
| Sep 30, 2021 | 31.35% |